Cargando…
Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267746/ https://www.ncbi.nlm.nih.gov/pubmed/22303468 http://dx.doi.org/10.1371/journal.pone.0030897 |
_version_ | 1782222319390818304 |
---|---|
author | Al-Hashmi, Sulaiman Boels, Piet J. M. Zadjali, Fahad Sadeghi, Behnam Sällström, Johan Hultenby, Kjell Hassan, Zuzana Arner, Anders Hassan, Moustapha |
author_facet | Al-Hashmi, Sulaiman Boels, Piet J. M. Zadjali, Fahad Sadeghi, Behnam Sällström, Johan Hultenby, Kjell Hassan, Zuzana Arner, Anders Hassan, Moustapha |
author_sort | Al-Hashmi, Sulaiman |
collection | PubMed |
description | Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on the pharmacology, physiology and structure of large elastic arteries and small resistance-sized arteries in a SCT mouse model. Mesenteric resistance arteries and aorta were dissected from Balb/c mice conditioned with busulphan (Bu) and cyclophosphamide (Cy). In vitro isometric force development and pharmacology, in combination with RT-PCR, Western blotting and electron microscopy were used to study vascular properties. Compared with controls, mesenteric resistance arteries from the Bu-Cy group had larger internal circumference, showed enhanced endothelium mediated relaxation and increased expression of endothelial nitric oxide synthase (eNOS). Bu-Cy treated animals had lower mean blood pressure and signs of endothelial injury. Aortas of treated animals had a higher reactivity to noradrenaline. We conclude that short-term consequences of Bu-Cy treatment divergently affect large and small arteries of the cardiovascular system. The increased noradrenaline reactivity of large elastic arteries was not associated with increased blood pressure at rest. Instead, Bu-Cy treatment lowered blood pressure via augmented microvascular endothelial dependent relaxation, increased expression of vascular eNOS and remodeling toward a larger lumen. The changes in the properties of resistance arteries can be associated with direct effects of the compounds on vascular wall or possibly indirectly induced via altered translational activity associated with the reduced hematocrit and shear stress. This study contributes to understanding the mechanisms that underlie the early effects of conditioning regimen on resistance arteries and may help in designing further investigations to understand the late effects on vascular system. |
format | Online Article Text |
id | pubmed-3267746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32677462012-02-02 Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase Al-Hashmi, Sulaiman Boels, Piet J. M. Zadjali, Fahad Sadeghi, Behnam Sällström, Johan Hultenby, Kjell Hassan, Zuzana Arner, Anders Hassan, Moustapha PLoS One Research Article Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on the pharmacology, physiology and structure of large elastic arteries and small resistance-sized arteries in a SCT mouse model. Mesenteric resistance arteries and aorta were dissected from Balb/c mice conditioned with busulphan (Bu) and cyclophosphamide (Cy). In vitro isometric force development and pharmacology, in combination with RT-PCR, Western blotting and electron microscopy were used to study vascular properties. Compared with controls, mesenteric resistance arteries from the Bu-Cy group had larger internal circumference, showed enhanced endothelium mediated relaxation and increased expression of endothelial nitric oxide synthase (eNOS). Bu-Cy treated animals had lower mean blood pressure and signs of endothelial injury. Aortas of treated animals had a higher reactivity to noradrenaline. We conclude that short-term consequences of Bu-Cy treatment divergently affect large and small arteries of the cardiovascular system. The increased noradrenaline reactivity of large elastic arteries was not associated with increased blood pressure at rest. Instead, Bu-Cy treatment lowered blood pressure via augmented microvascular endothelial dependent relaxation, increased expression of vascular eNOS and remodeling toward a larger lumen. The changes in the properties of resistance arteries can be associated with direct effects of the compounds on vascular wall or possibly indirectly induced via altered translational activity associated with the reduced hematocrit and shear stress. This study contributes to understanding the mechanisms that underlie the early effects of conditioning regimen on resistance arteries and may help in designing further investigations to understand the late effects on vascular system. Public Library of Science 2012-01-27 /pmc/articles/PMC3267746/ /pubmed/22303468 http://dx.doi.org/10.1371/journal.pone.0030897 Text en Al-Hashmi et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Al-Hashmi, Sulaiman Boels, Piet J. M. Zadjali, Fahad Sadeghi, Behnam Sällström, Johan Hultenby, Kjell Hassan, Zuzana Arner, Anders Hassan, Moustapha Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title | Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title_full | Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title_fullStr | Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title_full_unstemmed | Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title_short | Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase |
title_sort | busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267746/ https://www.ncbi.nlm.nih.gov/pubmed/22303468 http://dx.doi.org/10.1371/journal.pone.0030897 |
work_keys_str_mv | AT alhashmisulaiman busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT boelspietjm busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT zadjalifahad busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT sadeghibehnam busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT sallstromjohan busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT hultenbykjell busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT hassanzuzana busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT arneranders busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase AT hassanmoustapha busulphancyclophosphamidecauseendothelialinjuryremodelingofresistancearteriesandenhancedexpressionofendothelialnitricoxidesynthase |